Stocks
Anika Therapeutics (ANIK) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -106.3 | -3.05 | -2.72 | 70.4 | -29.8 | -27.1 | ||
| Changes by years, y/y, % | -81% | -97% | -11% | -2 686% | -142% | -44.5% | |||
Anika Therapeutics. EV/EBITDA
Anika Therapeutics. EV/EBITDA, changes, %
Anika Therapeutics (ANIK) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -139.7 | -30.6 | 4.97 | -27.1 | -39.0 | -27.1 | |
| Changes by years, y/y, % | -1 527% | -432% | -138% | -93% | -72% | |||
| Changes by quarters, q/q, % | -66% | -78% | -116% | -645% | +44% | |||
